Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains

被引:11
作者
Levin, Steven D. [1 ]
Evans, Lawrence S. [1 ]
Bort, Susan [1 ]
Rickel, Erika [1 ]
Lewis, Katherine E. [1 ]
Wu, Rebecca P. [1 ]
Hoover, Joseph [1 ]
MacNeil, Sean [1 ]
La, David [2 ]
Wolfson, Martin F. [1 ]
Rixon, Mark W. [1 ]
Dillon, Stacey R. [1 ]
Kornacker, Michael G. [1 ]
Swanson, Ryan [1 ]
Peng, Stanford L. [1 ]
机构
[1] Alpine Immune Sci Inc, Seattle, WA 98102 USA
[2] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
关键词
costimulation; protein engineering; protein therapeutics; anti-inflammatory; IgSF; ICOS ligand (ICOSL); CO-STIMULATION; T-CELLS; CD28; ANTIBODY; LIGAND; COSTIMULATION; BELATACEPT; ARTHRITIS; SEQUENCE; BINDING;
D O I
10.3389/fimmu.2019.03086
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunoglobulin superfamily member (IgSF) proteins play a significant role in regulating immune responses with surface expression on all immune cell subsets, making the IgSF an attractive family of proteins for therapeutic targeting in human diseases. We have developed a directed evolution platform capable of engineering IgSF domains to increase affinities for cognate ligands and/or introduce binding to non-cognate ligands. Using this scientific platform, ICOSL domains have been derived with enhanced binding to ICOS and with additional high-affinity binding to the non-cognate receptor, CD28. Fc-fusion proteins containing these engineered ICOSL domains significantly attenuate T cell activation in vitro and in vivo and can inhibit development of inflammatory diseases in mouse models. We also present evidence that engineered ICOSL domains can be formatted to selectively provide costimulatory signals to augment T cell responses. Our scientific platform thus provides a system for developing therapeutic protein candidates with selective biological impact for treatments of a wide array of human disorders including cancer and autoimmune/inflammatory diseases.
引用
收藏
页数:17
相关论文
共 36 条
[1]  
Behr TM, 2001, NEW ENGL J MED, V345, P995
[2]   SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information [J].
Biasini, Marco ;
Bienert, Stefan ;
Waterhouse, Andrew ;
Arnold, Konstantin ;
Studer, Gabriel ;
Schmidt, Tobias ;
Kiefer, Florian ;
Cassarino, Tiziano Gallo ;
Bertoni, Martino ;
Bordoli, Lorenza ;
Schwede, Torsten .
NUCLEIC ACIDS RESEARCH, 2014, 42 (W1) :W252-W258
[3]   Optimal screening of surface-displayed polypeptide libraries [J].
Boder, ET ;
Wittrup, KD .
BIOTECHNOLOGY PROGRESS, 1998, 14 (01) :55-62
[4]   The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans [J].
Brandt, Cameron S. ;
Baratin, Myriam ;
Yi, Eugene C. ;
Kennedy, Jacob ;
Gao, Zeren ;
Fox, Brian ;
Haldeman, Betty ;
Ostrander, Craig D. ;
Kaifu, Tomonori ;
Chabannon, Christian ;
Moretta, Alessandro ;
West, Robert ;
Xu, WenFeng ;
Vivier, Eric ;
Levin, Steven D. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (07) :1495-1503
[5]   ICOS controls the pool size of effector-memory and regulatory T cells [J].
Burmeister, Yvonne ;
Lischke, Timo ;
Dahler, Anja C. ;
Mages, Hans Werner ;
Lam, Kong-Peng ;
Coyle, Anthony J. ;
Kroczek, Richard A. ;
Hutloff, Andreas .
JOURNAL OF IMMUNOLOGY, 2008, 180 (02) :774-782
[6]   Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells [J].
Carmen Ochoa, Maria ;
Minute, Luna ;
Rodriguez, Inmaculada ;
Garasa, Saray ;
Perez-Ruiz, Elisabeth ;
Inoges, Susana ;
Melero, Ignacio ;
Berraondo, Pedro .
IMMUNOLOGY AND CELL BIOLOGY, 2017, 95 (04) :347-355
[7]   Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation [J].
Carter, LL ;
Carreno, BM .
IMMUNOLOGIC RESEARCH, 2003, 28 (01) :49-59
[8]   HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J].
CARTER, P ;
PRESTA, L ;
GORMAN, CM ;
RIDGWAY, JBB ;
HENNER, D ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, C ;
CARVER, ME ;
SHEPARD, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4285-4289
[9]   Isolating and engineering human antibodies using yeast surface display [J].
Chao, Ginger ;
Lau, Wai L. ;
Hackel, Benjamin J. ;
Sazinsky, Stephen L. ;
Lippow, Shaun M. ;
Wittrup, K. Dane .
NATURE PROTOCOLS, 2006, 1 (02) :755-768
[10]   Structural basis of inducible costimulator ligand costimulatory function: Determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein [J].
Chattopadhyay, Kausik ;
Bhatia, Sumeena ;
Fiser, Andras ;
Almo, Steven C. ;
Nathenson, Stanley G. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (06) :3920-3929